Lofgren Syndrome
- PMID: 29493940
- Bookshelf ID: NBK482315
Lofgren Syndrome
Excerpt
Lofgren syndrome is a clinically distinct phenotype of sarcoidosis, first described in 1946 by Swedish pulmonologist Sven Lofgren. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that commonly involves the lungs with the second most commonly affected organ being the skin. Cutaneous manifestations of sarcoidosis are seen in up to 33% of patients and may be the first clinical sign of the disease. In contrast to the often-insidious onset, slow disease progression and chronic disease course typical of sarcoidosis, Lofgren’s syndrome presents acutely. It typically presents in younger patients with acute onset erythema nodosum (EN), bilateral hilar lymphadenopathy, fever, and migratory polyarthritis, and without granulomatous skin involvement. Lofgren’s syndrome portends a favorable prognosis.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Siltzbach LE, James DG, Neville E, Turiaf J, Battesti JP, Sharma OP, Hosoda Y, Mikami R, Odaka M. Course and prognosis of sarcoidosis around the world. Am J Med. 1974 Dec;57(6):847-52. - PubMed
-
- Wanat KA, Rosenbach M. Cutaneous Sarcoidosis. Clin Chest Med. 2015 Dec;36(4):685-702. - PubMed
-
- Ponhold W. [The Löfgren syndrome: acute sarcoidosis (author's transl)]. Rontgenblatter. 1977 Jun;30(6):325-7. - PubMed
-
- JAMES DG, THOMSON AD, WILLCOX A. Erythema nodosum as a manifestation of sarcoidosis. Lancet. 1956 Aug 04;271(6936):218-21. - PubMed
-
- Ferrara G, Valentini D, Rao M, Wahlström J, Grunewald J, Larsson LO, Brighenti S, Dodoo E, Zumla A, Maeurer M. Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren's syndrome using high-content peptide microarrays. Int J Infect Dis. 2017 Mar;56:167-175. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials